Brady P. Gleason is a director in Sterne Kessler’s Trial & Appellate Practice Group, focusing on complex intellectual property disputes in the pharmaceutical, biotechnology, and mechanical and chemical engineering fields. In addition to his work litigating disputes in federal district courts, Brady also has experience in matters before the U.S. Court of Appeals for the Federal Circuit, the U.S. International Trade Commission in Section 337 investigations, and in inter partes review proceedings before the Patent Trial and Appeal Board.

Brady supports all phases of litigation, from the preparation of pleadings and defenses, to fact and expert discovery, dispositive motions practice, trial preparation and presentation, and through the exhaustion of appeals. He also works closely with in-house counsel, client leadership, scientists, industry experts, and expert witnesses on all litigation-related matters and other strategic initiatives on behalf of his clients.

Brady began his legal career as a law clerk for the Honorable Steven M. Wellner, Associate Judge, Superior Court of the District of Columbia, before serving as a law clerk for the Honorable Joseph R. Goodwin, United States District Judge, Southern District of West Virginia.

Brady received his J.D., magna cum laude, from The Catholic University of America Columbus School of Law with a concentration in intellectual property. During law school, he served as managing editor of the Catholic University Law Review, and he interned at the U.S. International Trade Commission, the U.S. District Court for the District of Columbia, and the U.S. Court of Appeals for the Federal Circuit.

Brady received his B.S. in biological sciences from Clemson University.

  • Corcept Therapeutics v. Teva Pharmaceuticals Inc. (D.N.J., Fed. Cir.) – on behalf of defendant, obtained non-infringement finding on both asserted patents after a bench trial.
  • Twinstrand Biosciences Guardant Health (D. Del., Fed. Cir.) – on behalf of plaintiff, obtained willful infringement finding and damages award of $83.4 million after a jury trial.
  • In re Certain Electronic Nicotine Delivery Systems and Components Thereof, 337-TA-1139 (counsel for Complainant Juul Labs, Inc. in an ITC Investigation involving electronic nicotine delivery systems).

  • J.D., Intellectual Property Concentration, The Catholic University of America Columbus School of Law, magna cum laude
  • B.S., Biological Sciences, Clemson University, cum laude

  • District of Columbia
  • U.S. Court of Appeals for the Fourth Circuit
  • Virginia
  • U.S. Court of Appeals for the Federal Circuit
  • U.S. District Court for the District of Columbia

  • The Honorable Joseph R. Goodwin, U.S. District Court for the Southern District of West Virginia
  • The Honorable Steven M. Wellner, Superior Court of the District of Columbia

Related News & Insights

From Brady P. Gleason

Firm News

January 7, 2026

Sterne Kessler Announces Three New Directors in 2026

Sterne, Kessler, Goldstein & Fox Multiple Authors

In the News

January 9, 2024

Teva Pharmaceuticals Successfully Defends Against Allegations of Patent Infringement

Parsippany Focus Multiple Authors

In the News

January 3, 2024

Teva Defeats Infringement Claims on Endocrine Drug

New Jersey Law Journal Multiple Authors

Firm News

January 3, 2024

Sterne Kessler Secures Non-Infringement Win for Teva Pharmaceuticals

Sterne, Kessler, Goldstein & Fox Multiple Authors

Firm News

November 15, 2023

Sterne Kessler Scores $83.4M Federal Jury Verdict for TwinStrand Biosciences, Inc.

Sterne, Kessler, Goldstein & Fox Multiple Authors

Firm News

August 29, 2023

U.S. District Court Affirms Immigrant Children’s Constitutional Rights

Sterne, Kessler, Goldstein & Fox Multiple Authors